INDUCTION OF PSA-SPECIFIC CYTOTOXIC T CELLS BY PEPTIDE-BASED IMMUNOTHERAPY

被引：0
|
作者：
Maurer, T. [1 ]
Pournaras, C. [1 ]
Aguilar-Pimentel, A. J. [2 ]
Heit, A. [3 ]
Gschwend, J. E. [1 ]
Kuebler, H. [1 ]
Nawroth, R. [1 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Urol, D-8000 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Dermatol & Allergol, D-8000 Munich, Germany
[3] Tech Univ Munich, Klinikum Rechts Isar, Dept Microbiol & Immunol, D-8000 Munich, Germany
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2009年 / 8卷 / 04期
关键词：
D O I：
10.1016/S1569-9056(09)60510-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：249 / 249
页数：1
相关论文
共 50 条
  • [1] Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity
    Ressing, ME
    Offringa, R
    Toes, REM
    Ossendorp, F
    deJong, JH
    Brandt, RMP
    Kast, WM
    Melief, CJM
    IMMUNOTECHNOLOGY, 1996, 2 (04): : 241 - 251
  • [2] A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols
    Lundberg, Kajsa
    Roos, Anna-Karin
    Pavlenko, Maxim
    Leder, Christoph
    Wehrum, Diana
    Guevara-Patino, Jose
    Andersen, Rikke Sick
    Pisa, Pavel
    VACCINE, 2009, 27 (10) : 1557 - 1565
  • [3] PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites
    Wong, BK
    Defeo-Jones, D
    Jones, RE
    Garsky, VM
    Feng, DM
    Oliff, A
    Chiba, M
    Ellis, JD
    Lin, JH
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (03) : 313 - 318
  • [4] Analysis of PSA-specific T Cell Response in PSA-transgenic Mouse: A Useful Model to Study Prostate Cancer Immunotherapy
    Dubey, Seema
    Karan, Dev
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 771 - 772
  • [5] Vaccination of dendritic cells with PSA encoding modified Vaccinia Virus Ankara (MVA-PSA) elicits PSA-specific T-cells in vitro
    Kübler, H
    Schmidt, B
    Drexler, I
    Sutter, G
    Hartung, R
    Bernhard, H
    Zantl, N
    JOURNAL OF UROLOGY, 2005, 173 (04): : 109 - 109
  • [6] Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes
    Wei, CW
    Storozynsky, E
    McAdam, AJ
    Yeh, KY
    Tilton, BR
    Willis, RA
    Barth, RK
    Looney, RJ
    Lord, EM
    Frelinger, JG
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 42 (06) : 362 - 368
  • [7] Peptide-Based Allergen Specific Immunotherapy for the Treatment of Allergic Disorders
    El-Qutob, David
    Reche, Pedro
    Subiza, Jose L.
    Fernandez-Caldas, Enrique
    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2015, 9 (01) : 16 - 22
  • [8] PEPTIDE-BASED IMMUNOTHERAPY IN SARCOMA
    Todorova, Roumiana
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2017, 70 (12): : 1689 - 1700
  • [9] Peptide-based immunotherapy of cancer
    Rammensee, H.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S12 - S12
  • [10] Development of an MHC class I Ld-restricted PSA peptide-loaded tetramer for detection of PSA-specific CD8+ T cells in the mouse
    C D Lemke
    J B Graham
    D M Lubaroff
    A K Salem
    Prostate Cancer and Prostatic Diseases, 2011, 14 : 118 - 121
12345